85 related articles for article (PubMed ID: 10425183)
1. Inhibition of Vpr-induced cell cycle abnormality by quercetin: a novel strategy for searching compounds targeting Vpr.
Shimura M; Zhou Y; Asada Y; Yoshikawa T; Hatake K; Takaku F; Ishizaka Y
Biochem Biophys Res Commun; 1999 Aug; 261(2):308-16. PubMed ID: 10425183
[TBL] [Abstract][Full Text] [Related]
2. Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): targeting Vpr and its cellular partner, the glucocorticoid receptor (GR).
Schafer EA; Venkatachari NJ; Ayyavoo V
Antiviral Res; 2006 Dec; 72(3):224-32. PubMed ID: 16889838
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
4. Fumagillin suppresses HIV-1 infection of macrophages through the inhibition of Vpr activity.
Watanabe N; Nishihara Y; Yamaguchi T; Koito A; Miyoshi H; Kakeya H; Osada H
FEBS Lett; 2006 May; 580(11):2598-602. PubMed ID: 16631749
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Vpr transactivates LTR-directed expression through sequences present within -278 to -176 and increases virus replication in vitro.
Vanitharani R; Mahalingam S; Rafaeli Y; Singh SP; Srinivasan A; Weiner DB; Ayyavoo V
Virology; 2001 Oct; 289(2):334-42. PubMed ID: 11689055
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
7. Pleiotropic effects of HIV-1 protein R (Vpr) on morphogenesis and cell survival in fission yeast and antagonism by pentoxifylline.
Zhao Y; Yu M; Chen M; Elder RT; Yamamoto A; Cao J
Virology; 1998 Jul; 246(2):266-76. PubMed ID: 9657945
[TBL] [Abstract][Full Text] [Related]
8. Establishment of latent HIV-1 infection of resting CD4(+) T lymphocytes does not require inactivation of Vpr.
Shen A; Siliciano JD; Pierson TC; Buck CB; Siliciano RF
Virology; 2000 Dec; 278(1):227-33. PubMed ID: 11112497
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathway.
Yoshizuka N; Yoshizuka-Chadani Y; Krishnan V; Zeichner SL
J Virol; 2005 Sep; 79(17):11366-81. PubMed ID: 16103188
[TBL] [Abstract][Full Text] [Related]
10. Hypophosphorylation of poly(A) polymerase and increased polyadenylation activity are associated with human immunodeficiency virus type 1 Vpr expression.
Mouland AJ; Coady M; Yao XJ; Cohen EA
Virology; 2002 Jan; 292(2):321-30. PubMed ID: 11878934
[TBL] [Abstract][Full Text] [Related]
11. Induction of M-phase arrest and apoptosis after HIV-1 Vpr expression through uncoupling of nuclear and centrosomal cycle in HeLa cells.
Watanabe N; Yamaguchi T; Akimoto Y; Rattner JB; Hirano H; Nakauchi H
Exp Cell Res; 2000 Aug; 258(2):261-9. PubMed ID: 10896777
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human immunodeficiency virus type 1 (HIV-1) nuclear import via Vpr-Importin alpha interactions as a novel HIV-1 therapy.
Suzuki T; Yamamoto N; Nonaka M; Hashimoto Y; Matsuda G; Takeshima SN; Matsuyama M; Igarashi T; Miura T; Tanaka R; Kato S; Aida Y
Biochem Biophys Res Commun; 2009 Mar; 380(4):838-43. PubMed ID: 19338763
[TBL] [Abstract][Full Text] [Related]
13. A carboxy-terminally truncated form of the Vpr protein of human immunodeficiency virus type 1 retards cell proliferation independently of G(2) arrest of the cell cycle.
Nishizawa M; Myojin T; Nishino Y; Nakai Y; Kamata M; Aida Y
Virology; 1999 Oct; 263(2):313-22. PubMed ID: 10544105
[TBL] [Abstract][Full Text] [Related]
14. Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues on Vpr-mediated transactivation and virus replication.
Thotala D; Schafer EA; Tungaturthi PK; Majumder B; Janket ML; Wagner M; Srinivasan A; Watkins S; Ayyavoo V
Virology; 2004 Oct; 328(1):89-100. PubMed ID: 15380361
[TBL] [Abstract][Full Text] [Related]
15. A novel inducible expression system to study transdominant mutants of HIV-1 Vpr.
Zhou Y; Ratner L
Virology; 2001 Aug; 287(1):133-42. PubMed ID: 11504548
[TBL] [Abstract][Full Text] [Related]
16. Multiple centrosome formation induced by the expression of Vpr gene of human immunodeficiency virus.
Minemoto Y; Shimura M; Ishizaka Y; Masamune Y; Yamashita K
Biochem Biophys Res Commun; 1999 May; 258(2):379-84. PubMed ID: 10329395
[TBL] [Abstract][Full Text] [Related]
17. Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr.
Shostak LD; Ludlow J; Fisk J; Pursell S; Rimel BJ; Nguyen D; Rosenblatt JD; Planelles V
Exp Cell Res; 1999 Aug; 251(1):156-65. PubMed ID: 10438581
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel Vpr-binding compound that inhibits HIV-1 multiplication in macrophages by chemical array.
Hagiwara K; Murakami T; Xue G; Shimizu Y; Takeda E; Hashimoto Y; Honda K; Kondoh Y; Osada H; Tsunetsugu-Yokota Y; Aida Y
Biochem Biophys Res Commun; 2010 Dec; 403(1):40-5. PubMed ID: 21036153
[TBL] [Abstract][Full Text] [Related]
19. Heat shock protein 70 protects cells from cell cycle arrest and apoptosis induced by human immunodeficiency virus type 1 viral protein R.
Iordanskiy S; Zhao Y; Dubrovsky L; Iordanskaya T; Chen M; Liang D; Bukrinsky M
J Virol; 2004 Sep; 78(18):9697-704. PubMed ID: 15331702
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 Vpr induces DNA double-strand breaks.
Tachiwana H; Shimura M; Nakai-Murakami C; Tokunaga K; Takizawa Y; Sata T; Kurumizaka H; Ishizaka Y
Cancer Res; 2006 Jan; 66(2):627-31. PubMed ID: 16423988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
